Love Maharashtra? Then you wil love Marathikatta!
Home Politics Religion Media Biz Society Tech Travel Books Intl. Autos Automobiles
                        Aviation   Pharma   About Us   Feedback   Links
USFDA SOURCING ANTI-HIV DRUGS FROM INDIAN COMPANIES

 

 

 

US FDA to source anti-HIV drugs from Indian firms

12 June, 2005

United States Food and Drug Administration (USFDA) has initiated the process to source anti-HIV drugs from Indian drug makers. 

BY OUR PHARMA CORRESPONDENT

Several of the anti-retrovirals (ARV) producers from India including the leading players like Cipla & Ranbaxy stand to benefit from this US dollar 15 billion President's Emergency Plan for AIDS Relief.

Under this scheme, the drug suppliers will get an expedited review and a waiver on the fee normally charged on new drug applications.

In an effort to source cheaper ARVs, a high profile FDA delegation was recently in Mumbai, holding talks with a couple of city-based drug makers.

According to sources, FDA is expected to complete the review process on ARV combinations within six weeks after receiving an application. The expedited review process would ensure that the US is providing safe, and effective combination, and single ingredient HIV therapies.

The expedited review process, combined with the work of local drug regulatory authorities in the affected countries, will provide a mechanism to ensure that safety, efficacy and quality standards are met and maintained by companies providing drugs for the Presidentís Emergency Plan.

In order to obtain approval of new products, manufacturers could cite existing clinical data to demonstrate the safety and efficacy of the individual drugs in the new product.

The FDA had also pledged to work with companies in assuring that necessary data are developed rapidly if the companies do not already have access to such data, sourced said.

BY OUR PHARMA CORRESPONDENT

Featured Business stories:

Contraceptive from Neem, courtesy DRDO  

100 per cent FDI in non-news media permitted  

IA lures peak season travellers  

Ranbaxy HIV/AIDS drug gets US FDA approval

India world's 3rd largest economy by 2030

Bluetooth shipments cross 5 million per week  

Seychelles has 2 of world's 3 most expensive hotels  

SEBI bars UBS for one year  

Last long, really long - new sex drug soon  

Thomas Cook plans to launch Forex ATMs 

Rahul Bajaj takes Force Motors to court

God's own airline  

CyberMedia announces IPO

Emirates Airline starts daily flights between Dubai, Seoul  
 
 Air India to buy 50 Boeings  

Credit policy 2005-2006  

Qatar Airways announces three new routes  

Diabetes drug Byetta approved by USFDA

Kingfisher Airlines takes flight

Kingfisher takes delivery of first Airbus 320  

Shoppers Stop IPO delayed, then permitted 

India Infoline IPO oversubscribed 7.34 times

HLL March Quarter results  

Hindustan Times files for IPO

NDTV Profit: Quick look

Ratan Tata: People's tycoon
DWS Man of the Year 2004

TCS picked by Ferrari for IT services

N R Narayana Murthy and the art of bluster

Jet Airways to go for Rs 1500 cr IPO

Royal Air, Kingfisher, Go race to the sky

Kerala's own budget airline?

Anil, Mukesh and Reliance - to split or not?

Birla Blues! The story so far

India Infoline announces IPO

Credit policy 2005-2006  

PERSONAL FINANCE

ABN Amro credit cards

Standard Chartered credit cards
 

Citibank India credit cards

ICICI Bank credit cards

HSBC Bank credit cards

ICICI Bank home loans

UTI Bank home loans

Archived Business Stories

 

Latest updates    Contact Us - Feedback    About Us